SentreHEART
Founded Year
2005Stage
Acquired | AcquiredTotal Raised
$69.02MValuation
$0000About SentreHEART
SentreHEART offers physicians precise control of remotely delivered suture for closure through developments in catheter technology and engineering expertise in remote suture delivery and tissue closure. The LARIAT Suture Delivery Device is indicated for suture placement and knot tying in surgical procedures where soft tissues are being approximated and/or ligated with a pre-tied polyester suture.
SentreHEART Headquarter Location
300 Saginaw Drive
Redwood City, California, 94063,
United States
650-354-1200
Research containing SentreHEART
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned SentreHEART in 1 CB Insights research brief, most recently on Aug 14, 2019.
Expert Collections containing SentreHEART
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
SentreHEART is included in 2 Expert Collections, including Medical Devices.
Medical Devices
11,001 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health IT
7,900 items
SentreHEART Patents
SentreHEART has filed 47 patents.
The 3 most popular patent topics include:
- Cardiac anatomy
- Cardiac arrhythmia
- Cardiac electrophysiology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/22/2017 | 1/18/2022 | Cardiac anatomy, Cardiac arrhythmia, Cardiac electrophysiology, Cardiology, Heart diseases | Grant |
Application Date | 9/22/2017 |
|---|---|
Grant Date | 1/18/2022 |
Title | |
Related Topics | Cardiac anatomy, Cardiac arrhythmia, Cardiac electrophysiology, Cardiology, Heart diseases |
Status | Grant |
Latest SentreHEART News
Nov 12, 2021
The report of Zion Market Research About Global Atrial Appendage Occluder Market Atrial Appendage Occluders Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast for 2016-2024 is an indispensable guide to position your business in a highly competitive market landscape. The report is tailored to the needs of our client and their current presence […] The post Boston Scientific, SentreHEART Inc., Occlutech, Coherex MedicalInc., AtriCureInc. – Politics for you appeared first on Archyworldys.
When was SentreHEART founded?
SentreHEART was founded in 2005.
Where is SentreHEART's headquarters?
SentreHEART's headquarters is located at 300 Saginaw Drive, Redwood City.
What is SentreHEART's latest funding round?
SentreHEART's latest funding round is Acquired.
How much did SentreHEART raise?
SentreHEART raised a total of $69.02M.
Who are the investors of SentreHEART?
Investors of SentreHEART include AtriCure, U.S. Venture Partners, Prospect Venture Partners, Vivo Capital, Deerfield Management and 3 more.
Who are SentreHEART's competitors?
Competitors of SentreHEART include Cerapedics, Svelte Medical Systems, MedShape, Celonova Biosciences, Transcend Medical and 11 more.
You May Also Like
Cerapedics is a privately held medical device company focused on developing and commercializing osteobiologic products based on its anorganic bone mineral (ABM) and synthetic small peptide (P-15) technology platform for use in a wide variety of spine, trauma and orthopedic surgical procedures. i-FACTOR bone graft is a biologic bone graft that utilizes a synthetic small peptide as an attachment factor intended to stimulate the natural bone healing process resulting in safe, predictable bone formation at a fraction of the cost of growth factors.
NeuroTrax is a medical device and technology company.
GLevel is a seed stage partnership between Three Arch Partners and Incept which is a syndicate of medical device entrepreneurs and clinicians starting new opportunities in the medical device space.
Cardiola have designed a patented device, the m.pulse device designed to treat chronic heart failure (CHF), non-surgically, in a patient's home.
synecor is a medical device developer
CoRepair, Inc. is developing a radiofrequency (RF) device system for the treatment of congestive heart failure.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.